Regenerative medicines deal with the process of engineering & replacing human cells, tissues or organs to restore or establish normal function. Regenerative medicines primarily help to restore structure and function of damaged tissues and organs by stimulating body’s own repair mechanism. These medicines are used in wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopedic applications.
Rising awareness among people regarding regenerative medicines, increasing government initiative across the globe and growing aging population & healthcare expenditure are considered to be the key factors driving the growth of global translational regenerative medicine market. However, higher cost of research and development and complex government approval processes are major restraints for global regenerative medicine market. Increase in adoption of regenerative medicines and growth in aging population expected to bring new opportunities for growth over the forecast period.
The report segments the translational regenerative medicine market by product type, by application and by region. Market segmentation based on type of product includes tissue engineered, cell based and gene therapy product. The application segment comprises orthopedic, dermatology, cardiology, neurology, oncology and others. Moreover, cardiology and orthopedic segments is the most dominating and fastest growing segment in the global translational regenerative medicine market.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, Latin America and Rest of the World. North America is the largest market for regenerative medicines and accounted highest market shares as of 2015. High medical reimbursement facilities and technological advancement in the region are considered to be the key factors driving the dominance of North America in global regenerative medicines market.
Following North America, Asia pacific is the second largest market for translational regenerative medicines and anticipated to witness healthy CAGR of XX% over the forecast period. The growth of Asia pacific is considered to driven by rapidly increasing aging population and per capita healthcare expenditure and higher focus on research in regenerative medicines across the region. Nevertheless, developing economies in Asia pacific such as India and China are likely to bring more opportunities for major player over the forecast period.
The companies covered in the report include Anika Therapeutics, Nuvasive, Inc., Orthofix International N.V., MEDIPOST, Athersys, Inc., Celgene Corporation, Vericel Corporation, Novartis, Brainstorm Cell Therapeutics Inc., Anterogen, Gamida Cell Ltd., RTI Surgical, Inc.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of translational regenerative medicine globally as well as regionally. Moreover, the author's growth matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of translational regenerative medicine market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the translational regenerative medicine market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the platelet rich plasma market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Translational Regenerative Medicine Market Overview
3.2 Market Dynamics
3.7 Porter’s Five Forces Analysis
3.8 Growth Matrix Analysis
3.9 Competitive Landscape in the Translational Regenerative Medicine Market
4. Global Translational Regenerative Medicine Market, by Product Type, (USD Million) 2014-2022
4.2 Tissue Engineered Products
4.3 Cell Based Products
4.4 Gene Therapy Products
5. Global Translational Regenerative Medicine Market, by Application, (USD Million) 2014-2022
6. Global Translational Regenerative Medicine Market, by Region, (USD Million) 2014-2022
6.2 North America
6.2.1 North America Translational Regenerative Medicine Market, by Product Type (USD Million)
6.2.2 North America Translational Regenerative Medicine Market, by Application (USD Million)
6.3.1 Europe Translational Regenerative Medicine Market, by Product Type (USD Million)
6.3.2 Europe Translational Regenerative Medicine Market, by Application (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Translational Regenerative Medicine Market, by Product Type (USD Million)
6.4.2 Asia Pacific Translational Regenerative Medicine Market, by Application (USD Million)
6.5 Latin America
6.5.1 Latin America Translational Regenerative Medicine Market, by Product Type (USD Million)
6.5.2 Latin America Translational Regenerative Medicine Market, by Application (USD Million)
6.6 Rest of the World
6.6.1 RoW America Translational Regenerative Medicine Market, by Product Type (USD Million)
6.6.2 RoW America Translational Regenerative Medicine Market, by Application (USD Million)
7. Leading Companies
7.1 Company Profiles
7.1.1 Anika Therapeutics
7.1.2 Nuvasive, Inc.
7.1.3 Orthofix International N.V.,
7.1.5 Athersys, Inc.
7.1.6 Celgene Corporation
7.1.7 Vericel Corporation
7.1.9 Brainstorm Cell Therapeutics Inc.
7.1.11 Gamida Cell Ltd.
7.1.12 RTI Surgical, Inc.
- Anika Therapeutics
- Athersys Inc.
- Brainstorm Cell Therapeutics Inc.
- Celgene Corporation
- Gamida Cell Ltd.
- Nuvasive Inc.
- Orthofix International N.V.
- RTI Surgical Inc
- Vericel Corporation